Skip to content
MenuOpen navigation menu

Real moms, real GLP-1 talk

Racing Heart on a GLP-1: The Questions I Would Ask

A higher resting pulse and palpitations need context. What the Wegovy label says, what to record, and when to seek emergency help.

Written by (pen name) — editorial research, not medical advice
On this page

A racing feeling needs its own conversation

If I noticed my heart racing while sitting still, I would report it rather than assume I was anxious or out of shape. Palpitations describe a sensation; they do not identify its cause. A watch reading can add information, but it cannot tell me by itself why the sensation happened.

I would separate that concern from ordinary breathlessness after carrying a toddler upstairs. My fatigue guide covers a different cluster of symptoms. When something feels new, I would describe it clearly instead of filing everything under the same side-effect heading.

What the Wegovy label actually says

In adult weight-reduction trials, Wegovy injection was associated with an average resting-heart-rate increase of one to four beats per minute compared with placebo. Its label calls for routine monitoring, reporting palpitations or a racing heartbeat at rest, and discontinuation if the increase in resting heart rate is sustained1. I would ask my prescriber how that instruction applies to me.

An average is not a personal ceiling. I would not dismiss a larger change because it falls outside the average, or conclude that every small variation is dangerous. I would also avoid applying one medicine's label automatically to another product. My exact drug and dose belong at the start of the discussion.

A symptom and a reading are useful together

I would record whether I felt pounding, fluttering, skipped beats or a fast steady pulse. I would note how long it lasted, whether I was resting, and whether it followed a dose change, exercise or an illness. I would include an actual measurement when available, without repeatedly checking until the numbers themselves become distressing.

NHLBI explains that arrhythmias can involve fast, slow or irregular heartbeats and may produce dizziness, fainting or shortness of breath2. I would not attempt to diagnose a rhythm from how it feels. I would ask whether an examination or an ECG is needed and what to do if the episode ends before the appointment.

Bring the whole day, not just the injection

I would tell the clinician about caffeine, prescription medicines, cold remedies, supplements, poor sleep and any recent vomiting or diarrhea. That is a request for a broader review, not an assertion that one of those explains the episode. I would bring names and amounts rather than say I take “nothing important.”

If I were having trouble drinking or eating, I would mention it early. The dehydration guide explains why that can deserve prompt attention. I would not treat an electrolyte drink as proof that a racing heartbeat has been evaluated, especially if the symptoms keep returning.

Watches are a record, not the verdict

If a device saved a tracing or notification, I would show the clinician the actual record and its time. I would explain whether I had symptoms at the same moment. A graph can be useful context, but I would not let a reassuring screen overrule a concerning episode.

I would ask what monitoring is appropriate instead of buying more devices immediately. My glucose-sensor guide makes the same practical point: a tool is most useful when it answers a defined clinical question. Measuring pulse and measuring glucose are different tasks, even when the same phone displays both.

Symptoms can make this an emergency

NHLBI advises calling emergency services for serious arrhythmia symptoms, including chest pain or difficulty breathing2. If racing or irregular heartbeats came with those symptoms, or with collapse, I would seek emergency help. I would not drive myself while faint or wait to see whether the next watch reading improves.

For recurring symptoms without those emergency features, I would contact the prescribing team promptly and ask what to do before the next dose. I would not make a trial-and-error plan with stimulants, supplements or someone else's medicine. The clinician needs to decide whether treatment should be held, changed or investigated.

Ask for a definition of follow-up

Before ending the conversation, I would want to know how to measure resting pulse, what pattern to report and who reviews the results. I would ask whether my next planned dose increase should proceed. My side-effect guide can help organize questions, but the answers must fit my history.

I would also ask when to expect a response if I send a symptom message. The goal is not to watch my pulse all day. It is to have a clear response to a new symptom, with enough room for both reassurance and proper evaluation.

References

  1. Novo Nordisk (2026). Wegovy prescribing information. Novo Nordisk. https://www.novo-pi.com/wegovy.pdf
  2. NHLBI (2022). Arrhythmias: symptoms. NHLBI. https://www.nhlbi.nih.gov/health/arrhythmias/symptoms

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.